The goal of aging research has fundamentally changed: instead of just adding years to your life, scientists now focus on adding life to your years. A growing body of research from institutions like Emory University reveals that while we've successfully extended human lifespan over the past century, the quality of those extra years remains uncertain. The gap between how long Americans live and how long they live in good health is about 12.4 years, meaning more than a decade spent in suboptimal health.

What Does "Aging Well" Actually Mean?

Aging well is not a single factor but a combination of interconnected elements that work together. Researchers at Emory emphasize that healthy aging depends on physical resilience, cognitive sharpness, social connection, access to care, and a sense of purpose. The encouraging news: while aging itself is inevitable, many aspects of how people age are not.

One of the most overlooked markers of healthy aging is mobility. Camille Vaughan, professor of medicine and director of Emory School of Medicine's Division of Geriatrics and Gerontology, explains that mobility signals far more than just physical strength.

"Our philosophies of health and aging are about keeping people engaged in doing the things they want to do," said Vaughan.

Camille Vaughan, Professor of Medicine and Director of Geriatrics and Gerontology, Emory School of Medicine

A patient who can stand up from a chair without using their arms, walk confidently, and remain engaged in daily activities is far more likely to maintain independence, even with chronic conditions like high blood pressure. Falls, often dismissed as accidents, are actually signals of deeper changes in strength, balance, or medication side effects that deserve clinical attention.

How to Build Physical Resilience as You Age

• Moderate Cardio Activity: Aim for about 30 minutes of moderate physical activity most days of the week. Moderate intensity means you can still talk while doing it, but not sing. This can include walking, swimming, or cycling.
• Strength Training and Balance Work: Include resistance exercises at least twice weekly, plus balance-focused activities. Chair stands, where you sit and stand without using your arms, are practical functional exercises that directly support daily independence.
• Reduce Prolonged Sitting: Long stretches of inactivity impair fat metabolism, worsen blood sugar control, and are linked to diabetes, heart disease, depression, dementia, and some cancers, independent of whether you exercise regularly.

The best exercise is the one you'll actually do consistently. Walking groups, tai chi, resistance bands, and programs like SilverSneakers all work. Emory researchers were involved in National Institutes of Health-funded trials three decades ago showing that tai chi can reduce falls in frail older adults, with the biggest benefits appearing after several months as participants built confidence and control.

Exercise timing matters less than once thought. Felipe Lobelo, associate professor of global health at Emory's Rollins School of Public Health, notes that federal guidelines recommend at least 150 minutes of moderate exercise or 75 minutes of vigorous exercise each week, plus strength training twice weekly. The key finding: as long as you meet the 150-minute weekly target, you get most of the health benefits, whether those minutes are spread throughout the week or concentrated on weekends.

Can a Popular Weight Loss Drug Actually Slow Aging?

Recent research has uncovered an unexpected benefit of GLP-1 agonist medications like semaglutide (the active ingredient in Ozempic and Wegovy). A randomized, placebo-controlled trial published in Nature Communications found that semaglutide may slow biological aging at the cellular level.

The study enrolled 108 adults with HIV and lipohypertrophy, a condition where excess fat accumulates around the abdomen. People with HIV often experience accelerated aging even when their condition is controlled with medication. About half received weekly semaglutide injections while the rest received a placebo. Over 32 weeks, researchers used biological epigenetic clocks, which estimate a person's biological age by measuring DNA methylation (chemical marks on DNA that regulate gene activity), to track cellular aging.

The results were striking: participants taking semaglutide showed slower biological aging overall, with slower aging specifically in the blood, brain, heart, kidney, liver, and metabolic measures. The medication slowed the pace of biological aging by 9 percent.

Experts believe the effect stems from multiple factors. Damian Folch, a family medicine physician affiliated with Lowell General Hospital, emphasizes that the most important mechanism is reducing inflammation. Fat cells, especially visceral fat deep in the belly, are inflammatory. By reducing body fat, the medication lowers overall inflammation in the body.

"The most important effect is in reducing inflammation. We know that fat cells are inflammatory, so reducing fat in your body, especially visceral fat or deep belly fat, has a big impact on overall inflammation," explained Folch.

Damian Folch, M.D., Family Medicine Physician, Lowell General Hospital

Chronic inflammation is linked to heart disease, cancer, and type 2 diabetes, all of which accelerate aging and reduce lifespan. Additionally, GLP-1 medications help maintain steadier blood sugar levels, which may further reduce inflammation. Weight loss also encourages increased physical activity and improved mental health, both important for the aging process.

However, important caveats remain. Most GLP-1 research has focused on people with type 2 diabetes, obesity, HIV, and other chronic diseases, populations that already have higher inflammation than the general population. It remains unclear whether these anti-aging benefits would extend to people without underlying inflammatory conditions. More research in the general population is needed before GLP-1s could be considered as medications specifically designed to slow aging.

Why We're Starting Longevity Research at the Wrong Time of Life

An international team of researchers is proposing a fundamental shift in how we approach longevity science. Instead of focusing primarily on older adults, they argue that longevity interventions should begin as early as possible, even before birth.

The researchers propose establishing PROSPER, the Pregestational and Pediatric Research for Optimal Healthspan and Early-life Resilience consortium. Their central argument: current longevity research focuses on adult populations, applying interventions only after decades of accumulated molecular and cellular changes have already occurred. This approach overlooks a critical window of opportunity in early life.

The researchers note that while past studies have examined childhood factors affecting lifespan, there's a lack of cohesive thinking about aging markers across the entire lifespan. The same aging markers used in adults mean something different in children. Biological age in early life reflects developmental synchrony and resilience rather than cumulative damage, requiring age-specific models and biomarkers.

PROSPER would integrate multiomics data (comprehensive biological measurements), clinical characteristics, and functional measures across all developmental stages to construct longitudinal biological trajectories. This would enable better risk prediction and earlier intervention. The consortium would also develop age-specific diagnostic and therapeutic frameworks that could be embedded in routine obstetric and pediatric care, shifting medicine from reactive disease management to proactive trajectory optimization.

The researchers also introduce the concept of "peakspan," the portion of life spent at peak performance. This offers another way to think about aging: not just how many years we live or how many are disease-free, but what proportion of our lives we spend in our prime.

While the PROSPER proposal is still in early stages and light on implementation details, its acceptance by the scientific community could fundamentally reshape longevity research and clinical practice. By aligning disciplines that have traditionally operated in isolation, researchers could address the full continuum of biological aging from its earliest determinants to its clinical manifestations in later life.